ATNM - Actinium Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATNM is currently covered by 1 analysts with an average price target of $48.96. This is a potential upside of $41.14 (526.09%) from yesterday's end of day stock price of $7.82.

Actinium Pharmaceuticals's activity chart (see below) currently has 0 price targets and 15 ratings on display. The stock rating distribution of ATNM is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ATNM is $50, Lowest price target is $50, average price target is $48.96.

Most recent stock forecast was given by JOSEPH PANTGINIS from HCWAINWRIGHT on 21-May-2024. First documented stock forecast 04-Jun-2020.

Best performing analysts who are covering ATNM - Actinium Pharmaceuticals:

Joseph Pantginis

Currently out of the existing stock ratings of ATNM, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

50

$42.18 (539.39%)

50

25 days ago

0/12 (0%)

$41.14 (464.33%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis has 18 price targets and 14 ratings on ATNM

Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $42.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?